The advantage of our study was that we measured the value of calretinin in several different subject groups (no disease, asbestosis, pleural plaques and MM) and that we were able to evaluate gender differences, the role of asbestos exposure and MM clinical parameters. This evidence concerns the gene CALB2 and Miyoshi myopathy.